Compare C J Gelatine with Similar Stocks
Dashboard
With HIgh Debt (Debt-Equity Ratio at 5.01 times)- the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 0% of over the last 5 years
- The company is Net-Debt Free
- The company has reported losses. Due to this company has reported negative ROE
Flat results in Dec 25
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 8 Cr (Micro Cap)
130.00
44
0.00%
5.01
1.44%
1.87
Total Returns (Price + Dividend) 
C J Gelatine for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

C J Gelatine Products Ltd Valuation Shifts Signal Renewed Price Attractiveness
C J Gelatine Products Ltd has undergone a notable shift in its valuation parameters, moving from an attractive to a very attractive price level despite a recent downgrade in its overall Mojo Grade to Sell. This article analyses the company’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios in comparison to historical averages and peer benchmarks, providing investors with a comprehensive view of its evolving market appeal.
Read full news article
C J Gelatine Products Ltd Valuation Shifts Amid Specialty Chemicals Sector Dynamics
C J Gelatine Products Ltd, a micro-cap player in the Specialty Chemicals sector, has experienced a notable shift in its valuation parameters, moving from a very attractive to a fair valuation grade. This change reflects evolving market perceptions amid a challenging industry backdrop and highlights the importance of scrutinising key metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to historical and peer benchmarks.
Read full news article
C J Gelatine Products Ltd Valuation Shifts Signal Changing Price Attractiveness
C J Gelatine Products Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, signalling a potential buying opportunity for investors seeking exposure in the specialty chemicals sector. Despite a challenging price-to-earnings (P/E) ratio of 123.22, the company’s price-to-book value (P/BV) of 1.77 and other valuation metrics suggest a more favourable entry point compared to its historical and peer averages.
Read full news article Announcements 
Disclosure On Large Corporate Entity
29-Apr-2026 | Source : BSEPursuant to provisions of various circulars issued by the SEBI with respect to large corporate entity we hereby inform you that our company does not fall under the definition of Large Corporate Entity; therefore the Company is not identified as a Large Corporate Entity as on March 31 2026. Please find enclosed herewith the necessary diclosures in this regards.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
15-Apr-2026 | Source : BSEPlease find attached herewith certificate received from RTA of the Company under Regulaiton 74(5) of the SEBI (DP) Regulations 2018 for the quarter ended March 31 2026.
Announcement under Regulation 30 (LODR)-Newspaper Publication
04-Apr-2026 | Source : BSEPlease find attached herewith copy of newspaper advertisement published by the Company on April 4 2026 pursuant to SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30 2026 with respect to special window for transfer and dematerialisation of Physical Shares.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Jaspal Singh (57.49%)
Krishan Kumar Amla (4.01%)
35.69%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -15.63% vs 43.25% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 175.00% vs 128.57% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 8.11% vs -5.67% in Sep 2024
Growth in half year ended Sep 2025 is 50.00% vs 86.11% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 2.71% vs 0.88% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 133.33% vs 98.27% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 0.98% vs 11.11% in Mar 2024
YoY Growth in year ended Mar 2025 is 104.10% vs -947.83% in Mar 2024






